Q2 2025 Earnings Call Transcript August 6, 2025 Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, ...

Official statistics from the district show that the prevalence rate of malaria in the general population reduced from 77 ...

As the progress in Apac District shows, the measures set up by the Ministry of Health, if followed properly, can lead to reduction in malaria that kills 16 Ugandans daily ...

Eight months into Donald Trump's second presidency of the United States, truth and science are again under attack – with ...

Discover Novavax's Q2 2025 earnings insights: raised revenue targets, cost reductions, key partnerships with Sanofi & Takeda, and progress in ...

Ghana has approved the world’s first malaria drug for newborns, marking a breakthrough in infant care. But as rollout nears, ...

Novavax ( ($NVAX) ) has risen by 24.00%. Read on to learn why. Novavax has experienced a notable 24.00% increase in its stock price over the past ...

After surviving nearly two years of genocide, Palestinians forced into a guarded zone on Rafah's rubble could face infectious disease likely to kill more people than the bombs ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the second quarter ended ...

Some Make America Healthy Again advocates are frustrated that Health Secretary Robert F. Kennedy Jr. has done little to hold ...

In straitened times, longer-term development should skew towards the poorest and most difficult countries even if that means ...

Chinese health officials are responding to an outbreak of a mosquito-borne disease that can cause severe joint pain. More ...